- Report
- February 2024
- 170 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- February 2024
- 172 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- November 2023
- 171 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- November 2023
- 90 Pages
France
From €3086EUR$3,500USD£2,691GBP
- Report
- November 2023
- 81 Pages
Germany
From €3086EUR$3,500USD£2,691GBP
- Report
- October 2023
- 81 Pages
Japan
From €3086EUR$3,500USD£2,691GBP
- Report
- March 2023
- 117 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- December 2022
- 111 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- November 2023
- 77 Pages
France
From €3086EUR$3,500USD£2,691GBP
- Report
- May 2024
- 130 Pages
Global
From €4870EUR$5,524USD£4,247GBP
€5730EUR$6,499USD£4,997GBP
- Report
- May 2024
- 138 Pages
Global
From €4870EUR$5,524USD£4,247GBP
€5730EUR$6,499USD£4,997GBP
- Report
- May 2024
- 129 Pages
Global
From €4870EUR$5,524USD£4,247GBP
€5730EUR$6,499USD£4,997GBP
- Report
- July 2024
- 150 Pages
Global
From €2645EUR$3,000USD£2,307GBP
€3306EUR$3,750USD£2,883GBP
- Report
- July 2024
- 150 Pages
Global
From €2645EUR$3,000USD£2,307GBP
€3306EUR$3,750USD£2,883GBP
- Report
- June 2024
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Report
- May 2023
- 450 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Report
- December 2024
- 200 Pages
Global
From €3306EUR$3,750USD£2,883GBP
- Report
- May 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,191GBP
- Report
- May 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,191GBP
- Report
- May 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,191GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more